Dual-luciferase assays revealed that the activity of BIRC5 was significantly decreased in NB cells with stable overexpression and increased by silencing of RUNX1, whereas NFKBIA and CSF2RB showed opposite results (Fig. 5c). The gene discussed is CSF2RB; the disease is neuroblastoma.